Page last updated: 2024-10-27

flucytosine and Breast Neoplasms

flucytosine has been researched along with Breast Neoplasms in 26 studies

Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
" siRNA targeting of choline kinase-α (Chk-α), an enzyme significantly up-regulated in aggressive breast cancer cells, was combined with the prodrug enzyme bacterial cytosine deaminase (bCD) that converts the nontoxic prodrug 5-fluorocytosine (5-FC) to cytotoxic 5-fluorouracil (5-FU)."3.76Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy. ( Artemov, D; Bhujwalla, ZM; Chen, Z; Li, C; Penet, MF; Takagi, T; Wildes, F; Winnard, PT, 2010)
"CD vectors converted the prodrug 5-fluorocytosine (5-FC) to the toxic nucleotide analog 5-fluorouracil in a breast cancer cell-specific manner, with a conversion rate of 40% and 52% in T47D cells and 50% and 41% in MCF7 cells, respectively."3.70Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach. ( Anderson, LM; Krotz, S; Thimmapaya, B; Weitzman, SA, 2000)
"Breast cancer is the most prevalent cancer in women worldwide and is classified into ductal and lobular carcinoma."2.48Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: evidence that they exert tumoricidal effects via tumor tropism (review). ( Choi, KC; Choi, KJ; Kim, SU; Yi, BR, 2012)
"The infected breast cancer cells did not show any significant changes in morphology, ultrastructure, cell growth, and cell‑cycle distribution compared to the uninfected cells."1.40Effects of an adenoviral vector containing a suicide gene fusion on growth characteristics of breast cancer cells. ( Huang, Z; Kong, H; Li, Q; Liu, C; Yang, L; Zhu, T, 2014)
" The major finding of this study is that the CD-annexin V fusion protein in combination with the prodrug 5-fluorocytosine has significant cytotoxic activity against endothelial cells and two breast cancer cells lines in vitro that expose phosphatidylserine on their surface."1.37Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine. ( Harrison, RG; Van Rite, BD, 2011)
"In subcutaneous MDA-MB-435 human breast cancer xenograft models, RRV-mediated yCD and TK suicide gene therapy significantly suppressed tumor growth after prodrug administration."1.36Highly efficient gene transfer to solid tumors in vivo by tumor-selective replicating retrovirus vectors. ( Lu, YC; Luo, YP; Tai, CK; Wang, YW, 2010)
"In nude mice bearing human breast cancer, the recombinant adenovirus vector was injected directly into the tumor followed by intraperitoneal injection of the prodrugs GCV and/or 5-FC, and the subsequent tumor growth was observed."1.35[Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro]. ( Huang, ZH; Kong, H; Li, Q; Li, Z; Yang, LC; Yu, JL, 2008)
"In vivo, MDA-MB-435 human breast cancer cells were implanted into the brain of immune-deficient mouse stereotactically, and F3."1.35Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases. ( Jin, J; Jo, MY; Joo, KM; Kang, BG; Kim, MH; Kim, SU; Lee, SJ; Nam, DH; Park, IH; Shin, JY, 2009)
"Human CD34(+) cells spiked with breast cancer cells were infected with an adenoviral vector encoding the cytosine deaminase transgene (Ad-CMV-CD)."1.31Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients. ( Alvarez, A; Avilés, MJ; Balas, A; Bueren, JA; Díez, JL; Fernández de Velasco, J; García-Castro, J; García-Sánchez, F; Gómez-Pineda, A; Lillo, R; Ramírez, M; Santos, S; Vicario, JL, 2002)
"Peripheral blood progenitor harvests of breast cancer patients are contaminated with tumor cells, suggesting a potential role for these cells in the relapse after high-dose chemotherapy."1.30Ex vivo breast cancer cell purging by adenovirus-mediated cytosine deaminase gene transfer and short-term incubation with 5-fluorocytosine completely prevents tumor growth after transplantation. ( Arnold, W; Dörken, B; Körner, IJ; Mapara, MY; Schumacher, A; Wolff, G, 1998)

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (11.54)18.2507
2000's9 (34.62)29.6817
2010's12 (46.15)24.3611
2020's2 (7.69)2.80

Authors

AuthorsStudies
Roy, S1
Brasino, M1
Beirne, JM1
Harguindey, A1
Chapnick, DA1
Liu, X1
Cha, JN1
Goodwin, AP1
Emamian, M1
Abbaspour, A1
Shahani, T1
Biglari, A1
Sharafi, A1
Altanerova, U1
Jakubechova, J1
Benejova, K1
Priscakova, P1
Pesta, M1
Pitule, P1
Topolcan, O1
Kausitz, J1
Zduriencikova, M1
Repiska, V1
Altaner, C2
Hickey, MJ1
Malone, CC1
Erickson, KL1
Lin, A1
Soto, H1
Ha, ET1
Kamijima, S1
Inagaki, A1
Takahashi, M1
Kato, Y1
Kasahara, N1
Mueller, BM1
Kruse, CA1
Kong, H3
Tao, L1
Qi, K1
Wang, Y1
Li, Q3
Du, J1
Huang, Z2
Kang, W1
Seol, HJ1
Seong, DH1
Kim, J1
Kim, Y1
Kim, SU4
Nam, DH2
Joo, KM2
Liu, C1
Zhu, T1
Yang, L1
Huang, ZH2
Yang, LC1
Yu, JL1
Li, Z1
Park, IH1
Shin, JY1
Jin, J1
Kang, BG1
Kim, MH1
Lee, SJ1
Jo, MY1
Lu, YC1
Luo, YP1
Wang, YW1
Tai, CK1
Li, C3
Penet, MF2
Wildes, F1
Takagi, T2
Chen, Z1
Winnard, PT2
Artemov, D3
Bhujwalla, ZM3
Van Rite, BD1
Harrison, RG1
Li, XH1
Zhou, P1
Wang, LH1
Tian, SM1
Qian, Y1
Chen, LR1
Zhang, P1
Kang, NH1
Hwang, KA1
Yi, BR2
Lee, HJ1
Jeung, EB1
Choi, KC2
Su, GQ1
Su, G1
Choi, KJ1
Lillo, R1
Ramírez, M1
Alvarez, A1
Santos, S1
García-Castro, J1
Fernández de Velasco, J1
Avilés, MJ1
Gómez-Pineda, A1
Díez, JL1
Balas, A1
Vicario, JL1
Bueren, JA1
García-Sánchez, F2
Akbulut, H1
Zhang, L1
Tang, Y1
Deisseroth, A1
Ramnaraine, M1
Pan, W1
Clohisy, DR1
Pastorakova, A1
Hlubinova, K1
Winnard, P1
Harris, JD1
Gutierrez, AA1
Hurst, HC1
Sikora, K1
Lemoine, NR1
Pizzorno, G1
Fu, SQ1
Nanakorn, T1
Krause, DS1
Liang, J1
Adams, E1
Leffert, JJ1
Yin, LH1
Cooperberg, MR1
Hanania, E1
Wang, WL1
Won, JH1
Peng, XY1
Cote, R1
Brown, R1
Burtness, B1
Giles, R1
Crystal, R1
Deisseroth, AB1
Wolff, G1
Körner, IJ1
Schumacher, A1
Arnold, W1
Dörken, B1
Mapara, MY1
Anderson, LM1
Krotz, S1
Weitzman, SA1
Thimmapaya, B1

Reviews

1 review available for flucytosine and Breast Neoplasms

ArticleYear
Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: evidence that they exert tumoricidal effects via tumor tropism (review).
    International journal of oncology, 2012, Volume: 41, Issue:3

    Topics: Breast Neoplasms; Camptothecin; Cytosine Deaminase; Female; Flucytosine; Fluorouracil; Ganciclovir;

2012

Other Studies

25 other studies available for flucytosine and Breast Neoplasms

ArticleYear
Enzymes Photo-Cross-Linked to Live Cell Receptors Retain Activity and EGFR Inhibition after Both Internalization and Recycling.
    Bioconjugate chemistry, 2020, 01-15, Volume: 31, Issue:1

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cytosine Deaminase; ErbB Receptors; Femal

2020
Non-viral Suicide Gene Therapy: Cytosine Deaminase Gene Directed by VEGF Promoter and 5-fluorocytosine as a Gene Directed Enzyme/prodrug System in Breast Cancer Model.
    Drug research, 2021, Volume: 71, Issue:7

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cytosine Deaminase; Escherichia coli; Female; Flucytosi

2021
Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes.
    International journal of cancer, 2019, 02-15, Volume: 144, Issue:4

    Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cytosine De

2019
Combined alloreactive CTL cellular therapy with prodrug activator gene therapy in a model of breast cancer metastatic to the brain.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Aug-01, Volume: 19, Issue:15

    Topics: Adenoviridae; Animals; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cytosine Deamin

2013
Thymidine kinase/ganciclovir and cytosine deaminase/5-fluorocytosine suicide gene therapy-induced cell apoptosis in breast cancer cells.
    Oncology reports, 2013, Volume: 30, Issue:3

    Topics: Adenoviridae; Antimetabolites; Antiviral Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cas

2013
Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.
    Oncology reports, 2013, Volume: 30, Issue:3

    Topics: Adenosine; Animals; Antimetabolites, Antineoplastic; Apoptosis; Blood-Brain Barrier; Blotting, Weste

2013
Effects of an adenoviral vector containing a suicide gene fusion on growth characteristics of breast cancer cells.
    Molecular medicine reports, 2014, Volume: 10, Issue:6

    Topics: Adenoviridae; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytosine Deaminase

2014
[Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2008, Volume: 28, Issue:6

    Topics: Adenoviridae; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyt

2008
Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2009, Volume: 17, Issue:3

    Topics: Animals; Brain Neoplasms; Breast Neoplasms; Cell Line; Cell Proliferation; Cell Survival; Coculture

2009
Highly efficient gene transfer to solid tumors in vivo by tumor-selective replicating retrovirus vectors.
    International journal of molecular medicine, 2010, Volume: 25, Issue:5

    Topics: Animals; Antimetabolites; Antiviral Agents; Breast Neoplasms; Cell Line; Cytosine Deaminase; Female;

2010
Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy.
    ACS nano, 2010, Nov-23, Volume: 4, Issue:11

    Topics: Animals; Bacteria; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplasti

2010
Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine.
    Cancer letters, 2011, Aug-01, Volume: 307, Issue:1

    Topics: Annexin A5; Antimetabolites; Aorta; Breast Neoplasms; Cell Survival; Cells, Cultured; Combined Modal

2011
The targeted gene (KDRP-CD/TK) therapy of breast cancer mediated by SonoVue and ultrasound irradiation in vitro.
    Ultrasonics, 2012, Volume: 52, Issue:1

    Topics: Analysis of Variance; Breast Neoplasms; Cell Line, Tumor; Contrast Media; Cytosine Deaminase; Female

2012
Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.
    Cancer gene therapy, 2012, Volume: 19, Issue:6

    Topics: Amniotic Fluid; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line

2012
Adenovirus-mediated tissue-targeted expression of the CDglyTk gene for the treatment of breast cancer.
    Molecular medicine reports, 2012, Volume: 6, Issue:2

    Topics: Adenoviridae; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Cycle;

2012
Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients.
    Cancer research, 2002, Sep-01, Volume: 62, Issue:17

    Topics: Adenoviridae; Animals; Bone Marrow Purging; Breast Neoplasms; Cytosine Deaminase; Female; Flucytosin

2002
Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Cancer gene therapy, 2003, Volume: 10, Issue:5

    Topics: Adenoviridae; Adenovirus E1A Proteins; Animals; Breast Neoplasms; Cell Death; Colonic Neoplasms; Cyt

2003
Osteoclasts direct bystander killing of cancer cells in vitro.
    Bone, 2006, Volume: 38, Issue:1

    Topics: Animals; Antimetabolites, Antineoplastic; Bone Marrow Cells; Bone Neoplasms; Breast Neoplasms; Cell

2006
Multimodal image-guided enzyme/prodrug cancer therapy.
    Journal of the American Chemical Society, 2006, Nov-29, Volume: 128, Issue:47

    Topics: Breast Neoplasms; Cell Line, Tumor; Cytosine Deaminase; Enzyme Stability; Flucytosine; Heterocyclic

2006
Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene.
    Neoplasma, 2006, Volume: 53, Issue:6

    Topics: Adenocarcinoma; Antimetabolites; Breast Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Cyto

2006
Image-guided enzyme/prodrug cancer therapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Jan-15, Volume: 14, Issue:2

    Topics: Animals; Breast Neoplasms; Catalogs, Drug as Topic; Cytosine Deaminase; Female; Flucytosine; Fluorou

2008
Gene therapy for cancer using tumour-specific prodrug activation.
    Gene therapy, 1994, Volume: 1, Issue:3

    Topics: Base Sequence; Biotransformation; Breast Neoplasms; Cytosine Deaminase; DNA Primers; Female; Flucyto

1994
Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.
    Blood, 1998, Jul-15, Volume: 92, Issue:2

    Topics: Adenoviridae; Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Cell Death; Cytosine Deami

1998
Ex vivo breast cancer cell purging by adenovirus-mediated cytosine deaminase gene transfer and short-term incubation with 5-fluorocytosine completely prevents tumor growth after transplantation.
    Human gene therapy, 1998, Oct-10, Volume: 9, Issue:15

    Topics: Adenoviridae; Animals; Antigens, CD34; Breast Neoplasms; Cytosine Deaminase; Female; Flucytosine; Fl

1998
Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach.
    Cancer gene therapy, 2000, Volume: 7, Issue:6

    Topics: Adenoviridae; Animals; Breast Neoplasms; Candida albicans; Carrier Proteins; Cell Survival; Cytosine

2000